| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |